drugset / Trial / NCT01887847
Pilot Pharmacokinetic Study of Investigational Sublingual Nicotine Tablet Versus COMMIT Nicotine Lozenge
Phase 1
Completed
6 enrolled
Pharmaceutical Productions Inc.
National Institute on Drug Abuse (NIDA) · collab
RandomizedCrossoverOpen-labelTreatment
Summary
The objective of this study is to compare the pharmacokinetics of an investigational 2 mg sublingual nicotine tablet (Pharmaceutical Productions Inc.) to a 2 mg Commit® nicotine lozenge (GlaxoSmith Kline) in a randomized crossover design in 6 male and female otherwise healthy smokers.
Timeline
- Start
- 2013-06
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Nicotine | Unknown | 2 mg | Other |
Indications
No indication recorded.